E155-0313 Screening compound: N-{2-[4-(4-fluorophenyl)piperazin-1-yl]-2-(pyridin-3-yl)ethyl}-3,4,5-trimethoxybenzamide

E155-0313 Screening compound: N-{2-[4-(4-fluorophenyl)piperazin-1-yl]-2-(pyridin-3-yl)ethyl}-3,4,5-trimethoxybenzamide
E155-0313 Screening compound: N-{2-[4-(4-fluorophenyl)piperazin-1-yl]-2-(pyridin-3-yl)ethyl}-3,4,5-trimethoxybenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E155-0313
N-{2-[4-(4-fluorophenyl)piperazin-1-yl]-2-(pyridin-3-yl)ethyl}-3,4,5-trimethoxybenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E155-0313

Molecular Formula

C27H31FN4O4 (C27 H31 FN4 O4)

Compound Name

N-{2-[4-(4-fluorophenyl)piperazin-1-yl]-2-(pyridin-3-yl)ethyl}-3,4,5-trimethoxybenzamide

IUPAC name

N-{2-[4-(4-fluorophenyl)piperazin-1-yl]-2-(pyridin-3-yl)ethyl}-345-trimethoxybenzamide

SMILES

COc1cc(C(NCC(c2cnccc2)N(CC2)CCN2c(cc2)ccc2F)=O)cc(OC)c1OC

InChI

InChI=1S/C27H31FN4O4/c1-34-24-15-20(16-25(35-2)26(24)36-3)27(33)30-18-23(19-5-4-10-29-17-19)32-13-11-31(12-14-32)22-8-6-21(28)7-9-22/h4-10,15-17,23H,11-14,18H2,1-3H3,(H,30,33)/t23-/m0/s1

InChI Key

SRYCICHEKTWEBM-QHCPKHFHSA-N

MDL Number (MFCD)

MFCD05894159

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

494.57

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.714

Distribution Coefficient, logD

2.714

Water Solubility, LogSw

-2.82

Polar Surface Area

63.397

Acid Dissociation Constant (pKa)

13.40

Base Dissociation Constant (pKb)

4.39

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

33.30

E155-0313 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

Antibacterial Compounds Library (13827 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Infections
  • Immune system
  • animal

References: we are preparing a list of scientific research reports with E155-0313 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E155-0313?
Check Price and Availability of E155-0313, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E155-0313 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E155-0313
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E155-0313
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E155-0313 available by request